Retatrutide (LY3437943) is a next-generation investigational peptide and a first-in-class triple receptor agonist targeting GLP-1, GIP, and glucagon pathways. It is widely studied in metabolic research for its multi-receptor activity and its role in exploring energy regulation and glucose metabolism mechanisms.